milnacipran has been researched along with Burning Mouth Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abiko, Y; Chiba, I; Giri, S; Matsuoka, H; Paudel, D; Toyofuku, A; Uehara, O; Utsunomiya, M; Yoshida, K | 1 |
| Aleksic, B; Arao, M; Iritani, S; Ishihara, R; Kimura, H; Kurita, K; Ozaki, N; Ukai, K; Yamauchi, A | 1 |
| Hori, H; Kodama, Y; Nakamura, J; Nakano, H; Sugita, A; Ueda, N; Umene, W; Yoshimura, R | 1 |
3 other study(ies) available for milnacipran and Burning Mouth Syndrome
| Article | Year |
|---|---|
Pharmacotherapy in relieving the symptoms of burning mouth syndrome: A 1-year follow-up study.
Topics: Adult; Aged; Amitriptyline; Benzodiazepines; Burning Mouth Syndrome; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Milnacipran; Pain Management; Pain Measurement; Retrospective Studies | 2020 |
Effectiveness of low-dose milnacipran for a patient suffering from pain disorder with delusional disorder (somatic type) in the orofacial region.
Topics: Burning Mouth Syndrome; Cyclopropanes; Dose-Response Relationship, Drug; Female; Glossalgia; Humans; Milnacipran; Schizophrenia, Paranoid; Somatoform Disorders; Treatment Outcome | 2013 |
Two cases of burning mouth syndrome treated with olanzapine.
Topics: Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Burning Mouth Syndrome; Cyclopropanes; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Milnacipran; Olanzapine; Paroxetine; Treatment Outcome | 2008 |